Prevalence of Iron Deficiency in Children with Down Syndrome

Department of Pediatrics, Hematology-Oncology, Duke University Medical Center, Durham, NC, USA.
The Journal of pediatrics (Impact Factor: 3.79). 12/2010; 157(6):967-971.e1. DOI: 10.1016/j.jpeds.2010.06.011
Source: PubMed


To determine the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) in a sample of children with Down syndrome (DS) and to evaluate the effect of macrocytosis on the diagnosis of ID/IDA in these children.
Children with DS ≥ 12 months of age who were followed at the Duke University Medical Center Comprehensive DS Clinic from December 2004 to March 2007 were screened for ID/IDA with a complete blood count, reticulocyte count, iron panel, and erythrocytic protoporphyrins.
A total of 114 children were enrolled, with a median age of 4.7 years. ID was identified in 12 subjects (10%), and IDA was identified in 3 subjects (3%). ID/IDA would not have been accurately diagnosed in 13 of 15 subjects (86%) if red blood cell (RBC) indices alone had been used for screening. Abnormal RBC indices with low transferrin saturation were 100% sensitive for ID/ IDA screening.
Prevalence of ID/IDA in children with DS was comparable with that in the general pediatric population. Macrocytosis had implications for screening of ID/IDA with only RBC indices. We suggest ID/IDA screening in DS children be done with a laboratory panel at least including complete blood count, reticulocyte count, transferrin saturation, and serum ferritin.

Full-text preview

Available from:
  • Source
    • "Depletion on APP in both cultured neurons and mouse models leads to intracellular iron retention that can be rescued upon the addition of APP to the extracellular environment (Duce et al., 2010) or by overexpression of cellular APP (Wan et al., 2012). Of significance, children suffering from Down's syndrome that have an increased expression of APP have a reported high risk of iron deficiency and anemia (Dixon et al., 2010; Tenenbaum et al., 2011), however, further investigation is required to confirm whether this is due to an increase in APP facilitated iron efflux. As with Fpn, it appears that the surface presence of APP is essential for its role in iron efflux. "
    [Show abstract] [Hide abstract]
    ABSTRACT: As with most bioavailable transition metals, iron is essential for many metabolic processes required by the cell but when left unregulated is implicated as a potent source of reactive oxygen species. It is uncertain whether the brain's evident vulnerability to reactive species-induced oxidative stress is caused by a reduced capability in cellular response or an increased metabolic activity. Either way, dys-regulated iron levels appear to be involved in oxidative stress provoked neurodegeneration. As in peripheral iron management, cells within the central nervous system tightly regulate iron homeostasis via responsive expression of select proteins required for iron flux, transport and storage. Recently proteins directly implicated in the most prevalent neurodegenerative diseases, such as amyloid-β precursor protein, tau, α-synuclein, prion protein and huntingtin, have been connected to neuronal iron homeostatic control. This suggests that disrupted expression, processing, or location of these proteins may result in a failure of their cellular iron homeostatic roles and augment the common underlying susceptibility to neuronal oxidative damage that is triggered in neurodegenerative disease.
    Frontiers in Pharmacology 04/2014; 5:81. DOI:10.3389/fphar.2014.00081 · 3.80 Impact Factor
  • Source
    • "comparable with their prevalence in the general pediatric population [16]. The paucity of data on the prevalence of anemia in DS patients of different age groups and the deleterious consequences associated with IDA lead us to investigate the prevalence of anemia in this population and the specific risk factors associated with IDA in children with DS. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Iron deficiency anemia impacts on cognitive development. The objective of this study was to determine the prevalence of anemia and iron deficiency in children with Down syndrome and identify risk factors for anemia. Methods. We conducted a prolective cross-sectional study of children attending a multidisciplinary Down syndrome medical center. One hundred and forty nine children with Down syndrome aged 0-20 years were enrolled in the study. Information obtained included a medical history, physical and developmental examination, nutritional assessment, and the results of blood tests. Results. Of the patients studied, 8.1% were found to have anemia. Among the 38 children who had iron studies, 50.0% had iron deficiency. In a multivariate analysis, Arab ethnicity and low weight for age were significantly associated with anemia. Gender, height, the presence of an eating disorder, and congenital heart disease were not risk factors for anemia. Conclusions. Children with Down syndrome are at risk for anemia and iron deficiency similar to the general population. Children with Down syndrome should be monitored for anemia and iron deficiency so that prompt intervention can be initiated.
    International Journal of Pediatrics 09/2011; 2011(12):813541. DOI:10.1155/2011/813541
  • [Show abstract] [Hide abstract]
    ABSTRACT: Für die Diagnosestellung der Anämie im Kindes- und Jugendalter ist das Blutbild unter Berücksichtigung der altersentsprechenden Normwerte von zentraler Bedeutung. Neben Anamnese und körperlicher Untersuchung liefert es richtungweisende Informationen zur Klassifizierung der Anämien, die häufig für die Differenzialdiagnose ausreichen. Erst im zweiten Schritt können gezielte, über das maschinelle Blutbild hinausreichende Laboruntersuchungen indiziert sein.
    Monatsschrift Kinderheilkunde 04/2012; 160(4). DOI:10.1007/s00112-012-2624-6 · 0.23 Impact Factor
Show more